Oxethazaine

SKU: orb1226646

Description

Oxethazaine is a topical anesthetic, in preventing acid-induced esophageal pain.(In Vivo):Oxetacaine (intraperitoneal injection; 5, 10, and 15 mg/kg; during days 4–11) doses induces significant conditioned place preference (CPP), and there are no differences among the groups. While its postive control group phentermine only 3 mg/kg causes significant CPP.\n.

Key Properties

• CAS Number: 126-27-2
• MW: 467.64
• Purity: >98% (HPLC)
• Formula: C₂₈H₄₁N₃O₃
• SMILES: OCCN(CC(N(C(C)(C)CC1=CC=CC=C1)C)=O)CC(N(C(C)(C)CC2=CC=CC=C2)C)=O
• Target: Sodium Channel
• Solubility: Soluble in DMSO

Bioactivity

• In Vivo:
  Oxetacaine (intraperitoneal injection; 5, 10, and 15 mg/kg; during days 4–11) doses induces significant conditioned place preference (CPP), and there are no differences among the groups. While its postive control group phentermine only 3 mg/kg causes significant CPP. Animal model: Male Wistar rats. Dosage: 5, 10, and 15 mg/kg; during days 4–11. Administration: Intraperitoneal injection. Result: Showed a significant CPP In vivo.
  Read more...

Storage & Handling

• Storage: Storage temperature: -20°C. Stability: ≥ 2 years
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Oxethazaine | WY 806 | Wy-806 | Oxetacaine | Emoren | FH 099

Quick Database Links

Gene Symbol

Sodium Channel